Clinical Trials Directory

Trials / Completed

CompletedNCT02670057

Sphenopalatine Ganglion Block to Treat Shoulder Pain During and/or After Cesarean

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
117 (actual)
Sponsor
NYU Langone Health · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this open label pilot study is to evaluate the utility of sphenopalatine ganglion (SPG) block to manage ipsilateral shoulder pain (ISP) during and/or after cesarean.

Detailed description

Shoulder pain thought to be caused by blood and amniotic fluid irritation of the diaphragm and nerves that supply the shoulder, can occur during and/or after a cesarean. Investigators will consent 100 patients, and will enroll 10 patients who develop ISP and have a score of is \>5/10 on the Verbal Analog pain Scale (VAS). Patients will be their own controls. Transnasal SPG block will be performed after childbirth, and and beginning at 20 minutes post treatment, the patient will be asked to rate their shoulder pain using the VAS a number of times.

Conditions

Interventions

TypeNameDescription
PROCEDURETransnasal SPG block

Timeline

Start date
2015-11-01
Primary completion
2017-12-12
Completion
2017-12-12
First posted
2016-02-01
Last updated
2017-12-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02670057. Inclusion in this directory is not an endorsement.